Sarah E Garner
Affiliation: National Institute for Health and Clinical Excellence
- Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectivesDavid Uguen
Voisin Consulting Life Sciences, Paris, France
Orphanet J Rare Dis 9:20. 2014..This paper presents perspectives on the current and emerging schemes for accelerating development of and access to medicines for rare diseases in the European Union. ..
- Reducing ineffective practice: challenges in identifying low-value health care using Cochrane systematic reviewsSarah Garner
National Institute for Health and Clinical Excellence, London
J Health Serv Res Policy 18:6-12. 2013..Our objective was to use Cochrane Reviews to identify low value practices to support local disinvestment decisions...
- Minocycline for acne vulgaris: efficacy and safetySarah E Garner
Research and Development, National Institute for Health and Clinical Excellence NICE, London, UK
Cochrane Database Syst Rev 8:CD002086. 2012..A modified-release version of minocycline is being promoted as having fewer side-effects...